MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 210 filers reported holding MEDICINES CO in Q2 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $982,000 | +17.3% | 19,635 | -14.4% | 0.20% | +12.5% |
| Q2 2019 | $837,000 | +37.4% | 22,945 | -27.9% | 0.18% | +69.2% |
| Q4 2018 | $609,000 | -4.5% | 31,840 | +49.2% | 0.10% | +57.6% |
| Q3 2018 | $638,000 | -12.6% | 21,335 | +7.2% | 0.07% | -89.8% |
| Q2 2018 | $730,000 | -33.4% | 19,897 | -40.2% | 0.64% | -32.2% |
| Q1 2018 | $1,096,000 | +13.8% | 33,271 | -5.5% | 0.95% | -21.3% |
| Q4 2017 | $963,000 | -3.9% | 35,217 | +30.1% | 1.21% | +794.8% |
| Q3 2017 | $1,002,000 | -2.6% | 27,060 | 0.0% | 0.14% | -12.3% |
| Q2 2017 | $1,029,000 | -25.5% | 27,060 | -4.2% | 0.15% | -37.4% |
| Q1 2017 | $1,381,000 | +59.3% | 28,251 | +10.6% | 0.25% | -5.0% |
| Q4 2016 | $867,000 | +34.6% | 25,534 | +49.6% | 0.26% | -16.7% |
| Q3 2016 | $644,000 | +28.3% | 17,070 | +14.4% | 0.31% | -16.6% |
| Q2 2016 | $502,000 | +3.1% | 14,919 | -2.7% | 0.37% | -44.4% |
| Q1 2016 | $487,000 | -14.9% | 15,331 | 0.0% | 0.67% | -57.3% |
| Q4 2015 | $572,000 | – | 15,331 | – | 1.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 4,202,000 | $153,246,000 | 19.10% |
| Antipodean Advisors LLC | 257,000 | $9,373,000 | 11.40% |
| Aviva Holdings Ltd. | 982,831 | $35,844,000 | 7.50% |
| BRIDGER MANAGEMENT, LLC | 2,314,014 | $84,392,000 | 6.62% |
| Slate Path Capital LP | 3,545,000 | $129,286,000 | 5.80% |
| CVI Holdings, LLC | 338,850 | $12,357,000 | 4.78% |
| DLD Asset Management, LP | 2,917,800 | $106,412,000 | 4.43% |
| Camber Capital Management LP | 1,700,000 | $61,999,000 | 2.89% |
| Maven Securities LTD | 109,386 | $3,994,000 | 2.66% |
| Parian Global Management LP | 110,100 | $4,015,000 | 2.60% |